Teva and Immunai partner to improve clinical decision making
The companies will focus on mechanisms of action, dose selection and biomarker analyses
Read MoreThe companies will focus on mechanisms of action, dose selection and biomarker analyses
Read MoreThe company’s workforce will volunteer and fundraise for Team Jak throughout the year
Read MorePrimary open-angle glaucoma affects around 2% of adults aged 40 years and older in the UK
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
